Inactive Instrument
HCi VioCare Stock OTC Bulletin Board
Stocks
US40416H1068
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
End-of-day quote
OTC Bulletin Board
|
||
| - USD | - |
|
| 21-05-17 | Rafina Innovations Inc. Announces Exclusive Distributor Agreement with Optec International Inc | CI |
| 21-04-21 | Rafina Innovations Inc. acquired C-PHARM Ltd. | CI |
| Market Cap | 1.38M 1.22M 1.15M 1.05M 1.96M 133M 1.98M 13.85M 5.34M 67.75M 5.19M 5.08M 218M | P/E 2017 |
-2.4x | P/E 2018 | -0.82x |
|---|---|---|---|---|---|
| Enterprise Value | 1.44M 1.27M 1.2M 1.09M 2.05M 138M 2.07M 14.45M 5.57M 70.7M 5.42M 5.3M 228M | EV / Sales 2017 |
23,123,686x | EV / Sales 2018 | 12,220,928x |
| Free-Float |
99% | Yield 2017 * |
-
| Yield 2018 | - |
| 22-08-19 | Rafina Innovations : Quarterly | PU |
| 22-04-13 | Rafina Innovations : Annual PE 12-31-2021 | PU |
| 21-11-15 | Rafina Innovations : Q3 09-30-2021 | PU |
| 21-05-25 | Rafina's Subsidiary C-Pharm Ltd Revenues for First Quarter 2021 $1.7 Million | GL |
| 21-05-18 | Rafina's Subsidiary C-Pharm Ltd Total Sales for 2020 $2.7 Million | GL |
| Manager | Title | Age | Since |
|---|---|---|---|
Roger Pawson
CEO | Chief Executive Officer | 73 | - |
Luke Joseph
AUD | Comptroller/Controller/Auditor | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Roger Pawson
BRD | Director/Board Member | 73 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.64% | -4.13% | -25.92% | +3.65% | 175B | |
| -0.71% | -3.24% | -9.27% | +11.11% | 111B | |
| -1.20% | +0.14% | -25.94% | -0.02% | 107B | |
| +1.00% | -2.60% | -47.08% | -10.76% | 75.31B | |
| -3.02% | -4.68% | -4.75% | +66.22% | 58.7B | |
| -1.06% | -1.19% | -3.64% | -30.03% | 49.57B | |
| +1.53% | +1.90% | +15.16% | +55.54% | 49.27B | |
| -1.68% | +1.04% | -17.45% | +22.39% | 42.02B | |
| -1.27% | -2.30% | +27.37% | -9.35% | 32.69B | |
| Average | -0.86% | -0.69% | -10.17% | +12.08% | 77.84B | |
| Weighted average by Cap. | -0.95% | -1.13% | -16.32% | +9.75% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 0.36 0.31 0.3 0.27 0.51 34.14 0.51 3.56 1.37 17.43 1.34 1.31 56.09 | 0.41 0.36 0.34 0.31 0.59 39.6 0.59 4.13 1.59 20.22 1.55 1.52 65.07 |
| Net income | -2.99M -2.64M -2.49M -2.26M -4.24M -287M -4.28M -29.92M -11.53M -146M -11.22M -10.97M -471M | -5.85M -5.16M -4.88M -4.43M -8.3M -561M -8.39M -58.6M -22.58M -287M -21.97M -21.49M -922M |
| Net Debt | -0.3 -0.27 -0.25 -0.23 -0.43 -29.23 -0.44 -3.05 -1.18 -14.92 -1.14 -1.12 -48.03 | 0.06 0.05 0.05 0.05 0.09 5.78 0.09 0.6 0.23 2.95 0.23 0.22 9.5 |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
